Joel Greenblatt fit · Magic Formula - ROIC alto + EV/EBIT barato
Is Soleno Therapeutics, Inc. Common Stock (SLNO) a Joel Greenblatt Stock?
Low Magic Formula score — expensive, low ROIC, or both.
0/100
FNo encaja
1/5 criterios cumplidos
Los criterios de Joel Greenblatt, aplicados a SLNO
EBIT/EV yield ≥ 10%
clave—
ROIC ≥ 25%
clave-60.0%
EV/EBIT ≤ 12
-10.2x
Gross margin ≥ 30%
98.1%
Cómo se valora SLNO en otras estrategias
Datos financieros en vivo
Cap. mercado
$2.76B
PER (TTM)
28.7x
ROIC (TTM)
15.35%
Margen bruto
98.63%
Otros análisis Joel Greenblatt
Preguntas frecuentes
What is SLNO's Joel Greenblatt fit score?
SLNO scores 0/100 on our Joel Greenblatt fit engine — grade F. Low Magic Formula score — expensive, low ROIC, or both.
Does Joel Greenblatt actually own SLNO?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends SLNO.
How often is this score updated?
SLNO's Joel Greenblatt fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Joel Greenblatt posea o recomiende SLNO personalmente.